Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H10O3 |
Molecular Weight | 154.1632 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCC1=CC(O)=C(O)C=C1
InChI
InChIKey=JUUBCHWRXWPFFH-UHFFFAOYSA-N
InChI=1S/C8H10O3/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,9-11H,3-4H2
Molecular Formula | C8H10O3 |
Molecular Weight | 154.1632 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Hydroxytyrosol is an important phenolic compound obtained from olive oil. Hydroxytyrosol possesses anti-inflammatory properties and has the capacity to inhibit cyclooxygenase and lipoxygenase enzymes. Hydroxytyrosol is a powerful antioxidant due to its protective function in cells. Hydroxytyrosol protects the cardiovascular system, avoiding oxidation of LDL cholesterol, maintaining normal blood HDL cholesterol concentrations and thus preventing atherosclerosis. Hydroxytyrosol protects brain cells from lipid peroxidation because it easy penetrates through the blood-brain barrier. Thus, the compound can be used in the disease treatment of Alzheimer or Parkinson. In addition, the compound also helps to prevent osteoporosis because its consumption has positive effects on the formation and growth of bones. Hydroxytyrosol is under investigation phase II clinical trials for breast cancer women to evaluate its effect on mammographic density. The recently published article has shown hydroxytyrosol could prevent obesity and insulin resistance by altering the composition of the intestinal microbiota and improving the integrity of the intestinal wall.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL215 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24568174 |
13.0 µM [IC50] |
PubMed
Title | Date | PubMed |
---|---|---|
Antioxidant effect of hydroxytyrosol (DPE) and Mn2+ in liver of cadmium-intoxicated rats. | 2002 Dec |
|
Antioxidants induce different phenotypes by a distinct modulation of signal transduction. | 2002 Dec 18 |
|
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. | 2002 Dec 30 |
|
Radioprotective effects in vivo of phenolics extracted from Olea europaea L. leaves against X-ray-induced chromosomal damage: comparative study versus several flavonoids and sulfur-containing compounds. | 2002 Fall |
|
Phenolic compounds profile of cornicabra virgin olive oil. | 2002 Nov 6 |
|
Production in large quantities of highly purified hydroxytyrosol from liquid-solid waste of two-phase olive oil processing or "Alperujo". | 2002 Nov 6 |
|
Influence of thermal treatments simulating cooking processes on the polyphenol content in virgin olive oil. | 2002 Oct 9 |
|
Olive oil phenolics: effects on DNA oxidation and redox enzyme mRNA in prostate cells. | 2002 Sep |
|
Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. | 2003 Apr 1 |
|
Quantitative changes in phenolic content during physiological development of the olive (Olea europaea) cultivar Hardy's Mammoth. | 2003 Apr 23 |
|
Environmental effects caused by olive mill wastewaters: toxicity comparison of low-molecular-weight phenol components. | 2003 Feb 12 |
|
Simultaneous determination of oleuropein and hydroxytyrosol in rat plasma using liquid chromatography with fluorescence detection. | 2003 Feb 25 |
|
Simultaneous determination of oleuropein and its metabolites in plasma by high-performance liquid chromatography. | 2003 Feb 25 |
|
Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. | 2003 Feb 25 |
|
Tyrosol and hydroxytyrosol are absorbed from moderate and sustained doses of virgin olive oil in humans. | 2003 Jan |
|
Changes in phenolic composition and antioxidant activity of virgin olive oil during frying. | 2003 Jan 29 |
|
Oxidative transformation of phenols in aqueous mixtures. | 2003 Jul |
|
In vitro formation of quinoid metabolites of the dietary supplement Cimicifuga racemosa (black cohosh). | 2003 Jul |
|
Activity and location of olive oil phenolic antioxidants in liposomes. | 2003 Jun |
|
Hydroxytyrosol disposition in humans. | 2003 Jun |
|
Differential effects of quercetin and resveratrol on Band 3 tyrosine phosphorylation signalling of red blood cells. | 2003 Jun 6 |
|
Grape and grape seed extract capacities at protecting LDL against oxidation generated by Cu2+, AAPH or SIN-1 and at decreasing superoxide THP-1 cell production. A comparison to other extracts or compounds. | 2003 May |
|
Isolation, structure elucidation and antioxidant potential of the major phenolic and flavonoid compounds in brined olive drupes. | 2003 May |
|
Antioxidant effect of phenolic compounds, alpha-tocopherol, and other minor components in virgin olive oil. | 2003 Nov 19 |
|
3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis. | 2003 Nov 7 |
|
Fast separation and determination of tyrosol, hydroxytyrosol and other phenolic compounds in extra-virgin olive oil by capillary zone electrophoresis with ultraviolet-diode array detection. | 2003 Sep 5 |
|
Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans. | 2004 |
|
Depsides from the petals of Papaver rhoeas. | 2004 Apr |
|
Polyphenol changes during fermentation of naturally black olives. | 2004 Apr 7 |
|
Olives and olive oil in cancer prevention. | 2004 Aug |
|
[Isolation and structural identification of C-glycosylflavones from Corallodiscus flabellata]. | 2004 Feb |
|
Effect of cultivar and processing method on the contents of polyphenols in table olives. | 2004 Feb 11 |
|
Biogenic amine formation and "zapatera" spoilage of fermented green olives: effect of storage temperature and debittering process. | 2004 Jan |
|
Toward a high yield recovery of antioxidants and purified hydroxytyrosol from olive mill wastewaters. | 2004 Jan 28 |
|
Production of highly purified hydroxytyrosol from Olea europaea leaf extract biotransformed by hyperthermophilic beta-glycosidase. | 2004 Jul 1 |
|
Removal of monomeric phenols in dry mill olive residue by saprobic fungi. | 2004 Jul 14 |
|
Antifungal constituents of Clytostoma ramentaceum and Mansoa hirsuta. | 2004 Jun |
|
Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation--a randomized controlled trial. | 2004 Jun |
|
Bioavailability and antioxidant effects of olive oil phenols in humans: a review. | 2004 Jun |
|
Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation. | 2004 Mar |
|
An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury. | 2004 Mar 1 |
|
Low-molecular-weight components of olive oil mill waste-waters. | 2004 May-Jun |
|
Qualitative and semiquantitative analysis of phenolic compounds in extra virgin olive oils as a function of the ripening degree of olive fruits by different analytical techniques. | 2004 Nov 17 |
|
Acid-induced structural modifications of unsaturated Fatty acids and phenolic olive oil constituents by nitrite ions: a chemical assessment. | 2004 Oct |
|
Total recovery of the waste of two-phase olive oil processing: isolation of added-value compounds. | 2004 Sep 22 |
|
Characterization of a new tyrosinase from Pycnoporus species with high potential for food technological applications. | 2005 |
|
[Studies on chemical constituents from the corm of Cremastra appendiculata]. | 2005 Apr |
|
Activity of olive oil phenols on lymphomonocyte cytosolic calcium. | 2005 Feb |
|
Identification and antioxidant potential of flavonoids and low molecular weight phenols in olive cultivar chemlali growing in Tunisia. | 2005 Jan 26 |
|
Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. | 2005 Jun |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/30884808
Hydroxytyrosol (HT) exert cardioprotective and anti-atherosclerotic effects. This study evaluates the effect of oral supplementation with HT on early atherosclerosis markers in middle-aged, seemingly healthy adults. The supplement was composed of 9.9 mg of HT
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:29:23 GMT 2023
by
admin
on
Fri Dec 15 18:29:23 GMT 2023
|
Record UNII |
QEU0NE4O90
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C275
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
||
|
DSLD |
3475 (Number of products:12)
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
||
|
NCI_THESAURUS |
C1327
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
600
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
68889
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
QEU0NE4O90
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
1314227
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID70147451
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
100000175320
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
HYDROXYTYROSOL
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
QEU0NE4O90
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
m6157
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB12771
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
C63690
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
82755
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
876
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
10597-60-1
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY | |||
|
837
Created by
admin on Fri Dec 15 18:29:23 GMT 2023 , Edited by admin on Fri Dec 15 18:29:23 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> ACTIVE CONSTITUENT ALWAYS PRESENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|